You are here

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Zuidlaren, , 9470 AE Netherlands
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy men or women of nonchildbearing potential aged 18 to 50 years,

- Body mass index in the range of 18 to 30 kg/m2 and body weight ≥50 kg.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Family history of sudden death and/or QT prolongation.

- An automatic ECG corrected QT (QTc) interval reading at screening >450 ms and >470 ms
for male and female subjects, respectively.

- Sinus bradycardia at screening, defined as a resting heart rate ?45 bpm. Resting
supine blood pressure at screening

NCT00452504
Pfizer
Completed
Single Ascending Dose Study of SRA-444 in Healthy Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Alzheimer Disease
NCT00676143
All Genders
50+
Years
Multiple Sites
Alzheimer Disease
NCT00726115
All Genders
18+
Years
Rueil Malmaison,
Alzheimer Disease
NCT00366483
All Genders
18+
Years
Paris,
Alzheimer Disease
NCT00663026
All Genders
50+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now